Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$92.83 -0.58 (-0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Selling, General & Administrative (2016 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Selling, General & Administrative of $67.45 million for Q2 2026, up 46.8% from $45.95 million a year earlier and up 6.1% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Selling, General & Administrative (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rhythm Pharmaceuticals' Selling, General & Administrative came in at $240.95 million, up 52.0% year-over-year; for FY2025, it came in at $194.94 million, up 35.1% from FY2024.

  • Selling, General & Administrative has increased for ten consecutive years, with a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $144.3 million in FY2024 (+22.8%), $117.53 million in FY2023 (+27.7%), $92.03 million in FY2022 (+34.4%) and $68.49 million in FY2021 (+48.5%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q3 2016.
  • Year over year, Selling, General & Administrative has now increased in each of the last 36 quarters, with growth averaging 35.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 13.7% (Q1 2025) to 62.7% (Q1 2026).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $63.59 million (Q1 2026), $57.48 million (Q4 2025) and $52.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Rhythm Pharmaceuticals 6.43 Bn 5.30 Bn 62.32 Mn 67.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.45 Mn
Mar 31, 2026 63.59 Mn
Dec 31, 2025 57.48 Mn
Sep 30, 2025 52.43 Mn
Jun 30, 2025 45.95 Mn
Mar 31, 2025 39.09 Mn
Dec 31, 2024 38.13 Mn
Sep 30, 2024 35.38 Mn
Jun 30, 2024 36.42 Mn
Mar 31, 2024 34.38 Mn
Dec 31, 2023 32.37 Mn
Sep 30, 2023 30.48 Mn
Jun 30, 2023 30.05 Mn
Mar 31, 2023 24.63 Mn
Dec 31, 2022 26.32 Mn
Sep 30, 2022 21.94 Mn
Jun 30, 2022 22.33 Mn
Mar 31, 2022 21.45 Mn
Dec 31, 2021 21.00 Mn
Sep 30, 2021 17.51 Mn
API Access

Rhythm Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RYTM&period=max&api_key=YOUR_API_KEY